Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

BACKGROUND: Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. METHODS: Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Particip...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ERJ Open Res
Hauptverfasser: Gibson, Peter G., Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Marks, Guy B., Baraket, Melissa, Powell, Heather, Simpson, Jodie L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: European Respiratory Society 2019
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6926362/
https://ncbi.nlm.nih.gov/pubmed/31886156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00056-2019
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge